The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...

The brain-computer interface technology personalizes therapy based on an individual’s brain activity.

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.

A 22-year-old male with extremely severe OCD underwent DBS and pulse generator implantation in September 2009. The patient and his family reported severe obsessive-compulsive symptomatology since ...